Ron Bentsur Nuvectis Pharma, Inc. (NVCT) insider trading activity
Ron Bentsur is Chairman & CEO of Nuvectis Pharma, Inc.. Currently has a direct ownership of 3.27 Million shares of NVCT, which is worth approximately $16.6 Million. The most recent transaction as insider was on May 16, 2023, when has been sold 320 shares (Common Stock) at a price of $17.02 per share, resulting in proceeds of $5,446. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3.27M
0.62%
3M change
0.89%
12M change
Total Value Held
$16.6 Million
RON BENTSUR Transaction History
Also insider at
RB
Ron Bentsur
Chairman & CEO
Garden City, NY